Cannusafe
Modern Slavery Statement (Voluntary)

Cannusafe Ltd is not a relevant commercial organisation under section 54 of the Modern Slavery Act 2015, as its turnover is below £36 million. We publish this statement voluntarily because we supply the NHS and believe that every supplier, whatever its size, should be able to account for the labour standards in its supply chain. This statement addresses the areas set out in section 54(5) of the Act.

Cannusafe Ltd is a UK micro-enterprise (Company No. 16768349, registered at Oaks Farm, Gotham Road, Nottingham NG11 0DF), founded and directed by a practising NHS consultant ophthalmologist. We own the design and intellectual property of the Cannusafe device, a sterile single-use adhesive tape used in intraocular surgery. Manufacture, pouching and sterilisation are performed by a single specialist medical adhesive-tape manufacturer in France under an ISO 13485-certified quality system; distribution is undertaken by appointed medical device distributors. Our supply chain is short and known to us: one manufacturer, its raw-material suppliers (polymer film, adhesive, release liner and packaging), an EU sterilisation subcontractor and freight providers.

We prohibit forced, bonded, compulsory, child and trafficked labour anywhere in our supply chain. Our Supplier Code of Conduct requires suppliers to guarantee freedom of movement, prohibit worker-paid recruitment fees, respect freedom of association and comply with all applicable labour law. The Code is issued to our manufacturer for counter-signature and applies at each contract renewal.

We have completed the Cabinet Office Modern Slavery Assessment Tool (MSAT) and shared the assessment with NHS Supply Chain Coordination. We obtain labour-standards attestations from our manufacturer, are mapping tier-2 raw-material origins by country using recognised risk indices, and require confirmation that the manufacturer’s Asia sourcing office applies equivalent standards to all purchasing on our behalf.

Direct manufacturing risk is low: production takes place in France under strong labour-law enforcement and EU regulatory oversight. Residual risk sits in upstream raw-material tiers with petrochemical and forestry origins, in any materials transiting higher-risk jurisdictions, and in freight and warehousing labour. These tiers are the focus of our mapping and attestation programme, supported by audit rights in supplier contracts and a remediation protocol that prioritises the protection of affected workers over supplier exit.

We measure our performance against the following indicators: the percentage of suppliers by spend signed to our Supplier Code of Conduct (target 100%); the percentage of tier-2 material origins mapped (target 100% within nine months); our annual MSAT score (maintained at 41% or above and improved year on year); and incidents identified and remediated (target: zero unresolved). This statement is reviewed and updated annually.

The Director, and any staff subsequently engaged, complete annual modern-slavery awareness training using UK Government resources.

This statement was approved by the Board of Cannusafe Ltd.

Mr Amar Alwitry FRCS FRCOphth MMedLaw

Director, Cannusafe Ltd

Date of publication: August 2026 · Next review: August 2027